Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes

Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges. What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Nutrition Business Journal (NBJ) will host its annual Raw Material & Ingredient Supply Web Seminar on January 14, 2009, from 11:00 a.m. to 12:30 p.m. Mountain time. NBJ’s editorial and research team, along with industry expert Thomas Aarts, will present a strategic analysis and review of the U.S. nutritional raw material & ingredient supply industry and offer insights into how supply companies are managing the current economic downturn, regulatory changes and other challenges. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Mediterranean Delights Introduces a New Line of "Hummus To Go" Snack Packs Mediterranean Delights has announced the launch of their new "Hummus To Go" snack pack. Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here Carlson Laboratories Annual Heart Month End-Cap Contest is Almost Here SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Global Partners Files Federal Lawsuit Against KGK Synergize SourceOne Files Suit Against KGK Synergize SourceOne Files Suit Against KGK Synergize SourceOne Files Suit Against KGK Synergize Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Navitas Naturals Introduces Organic Sweet Cacao Nibs Navitas Naturals has announced the release of their new Sweet Cacao Nibs. They can be eaten as a treat right out of the bag or they can add bold flavor and crunchy texture to a wide variety of recipes. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit. Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension Natural Alternatives International, Inc., has announced that effective December 31, 2008 its former President, Randell Weaver's employment with NAI ended. NAI also announced it completed certain amendments to its credit facility with Wells Fargo Bank. Among other changes the amendments extend the maturity date for the working capital line of credit from November 1, 2009 to November 1, 2010, while maintaining the current $7.5 million limit on the line of credit.	SAN FRANCISCO, Nov 21, 2005 /PRNewswire via COMTEX/ -- A preclinical study conducted at the University of Alberta shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance. The study, presented on Friday at the 3rd World Congress on Insulin Resistance Syndrome, is the first of its kind to show that chromium picolinate may improve endothelial function -- the overall health of the circulatory system -- and thus may limit macrovascular complications in pre-diabetes. "The rats used in the study are a unique animal model of human vascular disease that exhibit profound insulin resistance and cardiovascular disease, and they allow for the study of the relationships between insulin resistance and vascular function," said James C. Russell, PhD, the study's lead investigator and Professor Emeritus at the University of Alberta. "The protective micro and macrovascular effect of chromium picolinate observed in this model is significant as it demonstrates the need for additional investigation to further validate the use of the mineral as it relates to insulin resistance, type 2 diabetes and cardiovascular complications." The eight-week trial evaluated 30 rats using the JCR: LA-cp rat model developed by Dr. Russell. The study was designed to examine whether chromium picolinate could reduce the negative effects caused by insulin resistance. The JCR: LA-cp rats were used since these animals have the same micro and macrovascular complications associated with pre-diabetes in humans, including hypertension, high triglycerides and impaired kidney function. The study found that daily treatment with chromium picolinate increased relaxation of the blood vessels and improved blood flow to the heart. "These results are encouraging as it is the first time we are seeing the benefits of chromium picolinate in improving endothelial function," said James Komorowski, MS, Vice President of Technical Services and Scientific Affairs at Nutrition 21. "We look forward to the outcomes of two NIH clinical trials that are also examining the role of chromium picolinate in people with insulin resistance and cardiovascular disease risk factors." The study by Dr. Russell also showed an improvement in kidney function and in the severity of glomerular sclerosis in pre-diabetic rats treated with chromium picolinate, suggesting a potential renal protective benefit. This finding supports previous research demonstrating the safety of chromium picolinate and its potential benefits in liver and kidney functions. An earlier study published in the summer 2005 issue of Biological Trace Elements Research found that chromium picolinate improved kidney function in obese, diabetic mice. Animals were found to have reduced urinary albumin levels and improved renal chromium concentrations, compared with control group. About Pre-Diabetes According to the National Institute of Diabetes and Digestive and Kidney Diseases, many people with insulin resistance have high levels of blood glucose and high levels of insulin circulating in their blood at the same time. People with blood glucose levels that are higher than normal but not yet in the diabetic range have pre-diabetes (1). Recent research has shown that some long-term damage to the body, especially the heart and circulatory system, may already be occurring during pre-diabetes. Studies have also shown that most people with pre-diabetes develop type 2 diabetes within 10 years. People with pre-diabetes have a 1.5-fold risk of cardiovascular disease compared to people with normal blood glucose. There are 41 million people in the United States, ages 40 to 74, who have pre-diabetes. People with pre-diabetes can delay or prevent the onset of type 2 diabetes through lifestyle changes (2). About Nutrition 21 Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax(R) chromium picolinate, http://www.chromax.com/, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome(R), which is available through diabetes educators or at http://www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at http://www.nutrition21.com. (1) National Diabetes Information Clearinghouse. "Insulin Resistance and Pre-Diabetes." Retrieved November 16, 2005 from http://diabetes.niddk.nih.gov/dm/pubs/insulinresistance/. (2) American Diabetes Association. "Frequently Asked Questions about Pre-Diabetes." Retrieved November 16, 2005 from http://www.diabetes.org/pre-diabetes/faq.jsp.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software